NovoCure (NVCR) Non-Current Assets (2014 - 2026)

NovoCure (NVCR) has reported Non-Current Assets for 13 consecutive years, with $156.7 million the latest figure, recorded in Q2 2026.

• Quarterly Non-Current Assets fell 3.63% year-over-year to $156.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $156.7 million (down 3.63% YoY) and the FY2025 annual result came in at $157.6 million, up 17.43% from the prior year.
• Non-Current Assets steadied at $156.7 million in Q2 2026 per NVCR's latest filing, from $156.3 million in the prior quarter.
• Over the last five years, Non-Current Assets for NVCR reached as high as $162.6 million in Q2 2025 and fell as low as $68.1 million in Q2 2022.
• A 5-year average of $118.4 million and a median of $119.0 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 39.64% — and 2026, when it dropped 3.63%.
• Year by year, Non-Current Assets stood at $80.1 million in 2022, then jumped by 39.44% to $111.7 million in 2023, then gained by 20.13% to $134.2 million in 2024, then rose by 17.43% to $157.6 million in 2025, then declined by 0.59% to $156.7 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $156.7 million, $156.3 million, and $157.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.